Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20170307032933N3
IRCT20170307032933N3
Recruiting
未知

The Investigating of Radiation Protection Effects of Metformin in Patients with Prostate Cancer Treated with Radiotherapy

Ahvaz University of Medical Sciences0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsProstate cancer.Malignant neoplasm of prostate

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate cancer.
Sponsor
Ahvaz University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with localized prostate cancers that undergo definitive or postoperative external radiotherapy

Exclusion Criteria

  • •Patients with metastatic prostate cancer
  • •Patients previously treated with radiotherapy or chemotherapy
  • •Patients with renal or liver dysfunction
  • •Patients with severe respiratory diseases (such as obstructive pulmonary disorders or severe asthma)
  • •Patients with hematological disorders (such as severe anemia or vitamin B12 deficiency)
  • •Diabetic patients
  • •Smoker patients
  • •Metformin hypersensitivity

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
RANDOMIZED STUDY TO PROTECT FROM RADIATION IATROGENIC HYPOTHYROIDISM PATIENTS WITH MEDULLOBLASTOMA (ANY AGE, STAGE AND ANY BIOLOGICAL RISK) AND PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA AND NON-HODGKIN LYMPHOMA NEEDING RADIATION THERAPY ON THYROID SITE
EUCTR2021-001385-38-ITFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI51
Recruiting
Phase 1
The effect of under-the-table radiation shields to reduce scattering effect to operator performing cardiac catheterizatioradiation dose at chest and neck of operator
TCTR20181009003Phramongkutklao hospital200
Recruiting
Phase 1
Randomized study to protect from radiation iatrogenic hypothyroidism patients with medulloblastoma (any stage, any biological risk) and pediatric patients with Hodgkin lymphoma and non-Hodgkin lymphoma needing radiation therapy on thyroid site - WINHYPO 2021Hodgkin and non Hodgkin lymphoma, MedulloblastomaTherapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2024-512642-42-00Fondazione IRCCS Istituto Nazionale Dei Tumori65
Completed
Not Applicable
A study to evaluate the effects of irradiation by test product on the amount of ATP in the body.Healthy adults
JPRN-UMIN000040559imeQ RD inc.20
Completed
Not Applicable
A study to evaluate the effects of irradiation by test product on amount of ATP in the body Part2
JPRN-UMIN000041271imeQ RD inc.20